Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Lung Cancer

  Free Subscription


Articles published in Clin Lung Cancer

Retrieve available abstracts of 366 articles:
HTML format
Text format



Single Articles


    February 2020
  1. GERBER DE, Hamann HA, Chavez C, Dorsey O, et al
    Tracking the Nonenrolled: Lung Cancer Screening Patterns Among Individuals not Accrued to a Clinical Trial.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30035.
    PubMed     Text format     Abstract available


  2. MIYAWAKI T, Kenmotsu H, Mori K, Miyawaki E, et al
    Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30037.
    PubMed     Text format     Abstract available


  3. FORDE PM, Bonomi P, Shaw A, Blumenthal GM, et al
    Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30033.
    PubMed     Text format     Abstract available


  4. TAMBO Y, Sone T, Shibata K, Nishi K, et al
    Real-World Efficacy of First-Line Pembrolizumab in Patients With Advanced or Recurrent Non-Small-Cell Lung Cancer and High PD-L1 Tumor Expression.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30042.
    PubMed     Text format     Abstract available


  5. RITTBERG R, Green S, Aquin T, Bucher O, et al
    Effect of Hospitalization During First Chemotherapy and Performance Status on Small-cell Lung Cancer Outcomes.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30038.
    PubMed     Text format     Abstract available


  6. MARTIN C, Lupinacci L, Perazzo F, Bas C, et al
    Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina.
    Clin Lung Cancer. 2020 Feb 26. pii: S1525-7304(20)30039.
    PubMed     Text format     Abstract available


  7. BAEK J, Owen DH, Merritt RE, Shilo K, et al
    Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations.
    Clin Lung Cancer. 2020 Feb 25. pii: S1525-7304(20)30041.
    PubMed     Text format    


  8. ZHAO Y, Dong Y, Zhao R, Zhang B, et al
    Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
    Clin Lung Cancer. 2020 Feb 10. pii: S1525-7304(20)30020.
    PubMed     Text format     Abstract available


  9. O'NEILL RS, Mohd Zaki NI, Grant C, Napaki S, et al
    A Case of Non-Small-cell Lung Cancer in a Patient With Neurofibromatosis Type 1.
    Clin Lung Cancer. 2020 Feb 8. pii: S1525-7304(20)30019.
    PubMed     Text format    


  10. HOSOYA K, Fujimoto D, Morimoto T, Kumagai T, et al
    Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Clin Lung Cancer. 2020 Feb 4. pii: S1525-7304(20)30003.
    PubMed     Text format     Abstract available


    January 2020
  11. HANDA Y, Tsutani Y, Shiroma N, Kai Y, et al
    Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30013.
    PubMed     Text format     Abstract available


  12. RAJARAM R, Correa AM, Xu T, Nguyen QN, et al
    Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30009.
    PubMed     Text format     Abstract available


  13. TANAKA I, Morise M, Miyazawa A, Kodama Y, et al
    Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30011.
    PubMed     Text format     Abstract available


  14. PIZARRO G, Pinto MP, Munoz-Medel M, Cordova-Delgado M, et al
    Complete Response to Immunotherapy Plus Chemotherapy After an Unusual Clinical Response to Afatinib and Stereotactic Radiosurgery in a Patient With Metastatic EGFR-Mutant Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30012.
    PubMed     Text format    


  15. ARNOLD SM, Chansky K, Baggstrom MQ, Thompson MA, et al
    Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy.
    Clin Lung Cancer. 2020 Jan 27. pii: S1525-7304(20)30006.
    PubMed     Text format     Abstract available


  16. AHMED T, Lycan T, Dothard A, Ehrlichman P, et al
    Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Jan 23. pii: S1525-7304(20)30001.
    PubMed     Text format     Abstract available


  17. RAPHAEL J, Batra A, Boldt G, Shah PS, et al
    Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2020 Jan 3. pii: S1525-7304(19)30321.
    PubMed     Text format     Abstract available


    December 2019
  18. TSAO MN, Ven LI', Cheung P, Poon I, et al
    Stereotactic Body Radiation Therapy for Extracranial Oligometastatic Non-small-cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2019 Dec 30. pii: S1525-7304(19)30324.
    PubMed     Text format     Abstract available


  19. VOGEL J, Simone CB 2nd
    Patient-reported Outcomes With Stereotactic Body Radiotherapy and Surgery for Lung Cancer.
    Clin Lung Cancer. 2019 Dec 28. pii: S1525-7304(19)30372.
    PubMed     Text format    


  20. SENAN S, Okamoto I, Lee GW, Chen Y, et al
    Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study.
    Clin Lung Cancer. 2019 Dec 28. pii: S1525-7304(19)30374.
    PubMed     Text format     Abstract available


  21. ALBERTS L, Wolff HB, Kastelijn EA, Schramel FMNH, et al
    Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.
    Clin Lung Cancer. 2019 Dec 28. pii: S1525-7304(19)30373.
    PubMed     Text format    


  22. KARACZ CM, Yan J, Zhu H, Gerber DE, et al
    Timing, Sites, and Correlates of Lung Cancer Recurrence.
    Clin Lung Cancer. 2019 Dec 20. pii: S1525-7304(19)30344.
    PubMed     Text format     Abstract available


  23. SHAH R, Lester JF
    Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations.
    Clin Lung Cancer. 2019 Dec 20. pii: S1525-7304(19)30346.
    PubMed     Text format     Abstract available


  24. FUKIHARA J, Sakamoto K, Koyama J, Ito T, et al
    Reply to "Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors".
    Clin Lung Cancer. 2019 Dec 2. pii: S1525-7304(19)30330.
    PubMed     Text format    


    November 2019
  25. GUNJUR A, Chong G, Lim A, Lau E, et al
    Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report.
    Clin Lung Cancer. 2019 Nov 29. pii: S1525-7304(19)30331.
    PubMed     Text format    


  26. STEFFEN MCLOUTH LE, Lycan TW Jr, Levine BJ, Gabbard J, et al
    Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.
    Clin Lung Cancer. 2019 Nov 29. pii: S1525-7304(19)30332.
    PubMed     Text format     Abstract available


  27. SKOUGAARD K, Ostrup O, Guldbrandsen K, Sorensen B, et al
    Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy: A Randomized Controlled Trial (SUPER).
    Clin Lung Cancer. 2019 Nov 21. pii: S1525-7304(19)30319.
    PubMed     Text format     Abstract available


  28. BYEON S, Lee B, Park WY, Choi YL, et al
    Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
    Clin Lung Cancer. 2019 Nov 21. pii: S1525-7304(19)30323.
    PubMed     Text format     Abstract available


  29. PATIL T, Mushtaq R, Marsh S, Azelby C, et al
    Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Nov 21. pii: S1525-7304(19)30325.
    PubMed     Text format     Abstract available


  30. HOCHMAIR MJ, Setinek U, Krenbek D, Fazekas A, et al
    Rapid Clinical and Radiologic Responses With Larotrectinib Treatment in a Patient With TRK-Fusion-Positive Metastatic Lung Cancer.
    Clin Lung Cancer. 2019 Nov 20. pii: S1525-7304(19)30327.
    PubMed     Text format    


  31. SURESH K, Naidoo J
    Lower Survival in Patients Who Develop Pneumonitis Following Immunotherapy for Lung Cancer.
    Clin Lung Cancer. 2019 Nov 6. pii: S1525-7304(19)30283.
    PubMed     Text format    


  32. JELINEK MJ, Armstrong SA, Patel JD, Subramaniam DS, et al
    Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy.
    Clin Lung Cancer. 2019;20:e597-e600.
    PubMed     Text format    


  33. GUISIER F, Piton N, Salaun M, Thiberville L, et al
    ROS1-rearranged NSCLC With Secondary Resistance Mutation: Case Report and Current Perspectives.
    Clin Lung Cancer. 2019;20:e593-e596.
    PubMed     Text format    


  34. MODING EJ, Liang R, Lartey FM, Maxim PG, et al
    Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors.
    Clin Lung Cancer. 2019;20:461-468.
    PubMed     Text format     Abstract available


  35. PROTO C, Signorelli D, Mallone S, Prelaj A, et al
    The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
    Clin Lung Cancer. 2019;20:e652-e660.
    PubMed     Text format     Abstract available


  36. SCHULZ C, Gandara D, Berardo CG, Rosenthal R, et al
    Comparative Efficacy of Second- and Subsequent-line Treatments for Metastatic NSCLC: A Fractional Polynomials Network Meta-analysis of Cancer Immunotherapies.
    Clin Lung Cancer. 2019;20:451-460.
    PubMed     Text format     Abstract available


    October 2019
  37. LE T, Yang H, Rashdan S, Link MS, et al
    QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care.
    Clin Lung Cancer. 2019 Oct 31. pii: S1525-7304(19)30212.
    PubMed     Text format     Abstract available


  38. LELEU O, Basille D, Auquier M, Clarot C, et al
    Lung Cancer Screening by Low-Dose CT Scan: Baseline Results of a French Prospective Study.
    Clin Lung Cancer. 2019 Oct 31. pii: S1525-7304(19)30288.
    PubMed     Text format     Abstract available


  39. BEGNAUD A, Yang P, Robichaux C, Rubin N, et al
    Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities.
    Clin Lung Cancer. 2019 Oct 30. pii: S1525-7304(19)30286.
    PubMed     Text format     Abstract available


  40. ZHANG N, Wu J, Yu J, Zhu H, et al
    Integrating Imaging, Histologic, and Genetic Features to Predict Tumor Mutation Burden of Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Oct 25. pii: S1525-7304(19)30290.
    PubMed     Text format     Abstract available


  41. DENG HY, Peng L
    Surgery or Stereotactic Body Radiotherapy for Early-stage Lung Cancer: What Is the Current Evidence?
    Clin Lung Cancer. 2019 Oct 22. pii: S1525-7304(19)30285.
    PubMed     Text format    


  42. CHAN ST, Ruan D, Shaverdian N, Raghavan G, et al
    Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.
    Clin Lung Cancer. 2019 Oct 21. pii: S1525-7304(19)30284.
    PubMed     Text format     Abstract available


  43. JACOBS CD, Gao J, Wang X, Clarke JM, et al
    Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
    Clin Lung Cancer. 2019 Oct 19. pii: S1525-7304(19)30270.
    PubMed     Text format     Abstract available


  44. DIGUMARTHY SR, Mendoza DP, Lin JJ, Chen T, et al
    Computed Tomography Imaging Features and Distribution of Metastases in ROS1-rearranged Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Oct 16. pii: S1525-7304(19)30271.
    PubMed     Text format     Abstract available


  45. ROGASCH JMM, Furth C, Chibolela C, Hofheinz F, et al
    Validation of Independent Prognostic Value of Asphericity of (18)F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative Intent.
    Clin Lung Cancer. 2019 Oct 15. pii: S1525-7304(19)30266.
    PubMed     Text format     Abstract available


  46. KNEUERTZ PJ, D'Souza DM, Richardson M, Abdel-Rasoul M, et al
    Long-Term Oncologic Outcomes After Robotic Lobectomy for Early-stage Non-Small-cell Lung Cancer Versus Video-assisted Thoracoscopic and Open Thoracotomy Approach.
    Clin Lung Cancer. 2019 Oct 13. pii: S1525-7304(19)30269.
    PubMed     Text format     Abstract available


  47. KOBAYASHI K, Nakachi I, Mitsuishi A, Arai D, et al
    Successful Retreatment Using Pembrolizumab for Non-small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report.
    Clin Lung Cancer. 2019 Oct 13. pii: S1525-7304(19)30023.
    PubMed     Text format    


  48. OWEN B, Gandara D, Kelly K, Moore E, et al
    CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Oct 8. pii: S1525-7304(19)30253.
    PubMed     Text format     Abstract available


  49. BENNOUNA J, Girard N, Audigier-Valette C, le Thuaut A, et al
    Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial.
    Clin Lung Cancer. 2019 Oct 1. pii: S1525-7304(19)30265.
    PubMed     Text format     Abstract available


    September 2019
  50. WIDICK P, Gill RR, Mantia C, Costa DB, et al
    Extensive-Stage Small-Cell Lung Cancer With Sustained Complete Response to Single-Agent Nivolumab and Immune-Related Dermatitis.
    Clin Lung Cancer. 2019 Sep 26. pii: S1525-7304(19)30263.
    PubMed     Text format    


  51. AL-OBEIDI E, Li T, Kelly K
    Durable Responses to Afatinib as First-line Therapy for HER2-mutated Metastatic Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Sep 26. pii: S1525-7304(19)30264.
    PubMed     Text format    


  52. XIA H, Xue X, Ding H, Ou Q, et al
    Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Clin Lung Cancer. 2019 Sep 26. pii: S1525-7304(19)30262.
    PubMed     Text format     Abstract available


  53. PHAM D, Bhandari S, Pinkston C, Oechsli M, et al
    Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized.
    Clin Lung Cancer. 2019 Sep 26. pii: S1525-7304(19)30260.
    PubMed     Text format     Abstract available


  54. RICE SR, Vyfhuis MAL, Scilla KA, Burrows WM, et al
    Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
    Clin Lung Cancer. 2019 Sep 18. pii: S1525-7304(19)30258.
    PubMed     Text format     Abstract available


    August 2019
  55. DUMA N, Idossa DW, Durani U, Frank RD, et al
    Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Aug 30. pii: S1525-7304(19)30254.
    PubMed     Text format     Abstract available


  56. AGULLO-ORTUNO MT, Gomez-Martin O, Ponce S, Iglesias L, et al
    Blood Predictive Biomarkers for Patients With Non-small-cell Lung Cancer Associated With Clinical Response to Nivolumab.
    Clin Lung Cancer. 2019 Aug 30. pii: S1525-7304(19)30255.
    PubMed     Text format     Abstract available


  57. WU GX, Ituarte PHG, Ferrell B, Sun V, et al
    Causes of Death and Hospitalization in Long-term Lung Cancer Survivors: A Population-based Appraisal.
    Clin Lung Cancer. 2019 Aug 30. pii: S1525-7304(19)30256.
    PubMed     Text format     Abstract available


  58. DAL MASO A, Lorenzi M, Roca E, Pilotto S, et al
    Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
    Clin Lung Cancer. 2019 Aug 5. pii: S1525-7304(19)30213.
    PubMed     Text format     Abstract available


  59. HEEKE S, Benzaquen J, Hofman V, Ilie M, et al
    Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).
    Clin Lung Cancer. 2019 Aug 3. pii: S1525-7304(19)30214.
    PubMed     Text format     Abstract available


  60. BOVER M, Yarza R, Docampo LI
    Four-Year Lasting Sustained Complete Response After Nivolumab in a Patient With Non-Small-Cell Lung Cancer and Confirmed Leptomeningeal Carcinomatosis: Changing the Paradigm.
    Clin Lung Cancer. 2019 Aug 3. pii: S1525-7304(19)30216.
    PubMed     Text format    


  61. UPRETY D, Arjyal L, Vallatharasu Y, Bista A, et al
    Utilization of Surgery and Its Impact on Survival in Patients With Early Stage Small-cell Lung Cancer in the United States.
    Clin Lung Cancer. 2019 Aug 2. pii: S1525-7304(19)30217.
    PubMed     Text format     Abstract available


  62. MITCHELL KG, Farooqi A, Ludmir EB, Corsini EM, et al
    Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Aug 1. pii: S1525-7304(19)30211.
    PubMed     Text format     Abstract available


  63. FUKIHARA J, Sakamoto K, Koyama J, Ito T, et al
    Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors.
    Clin Lung Cancer. 2019 Aug 1. pii: S1525-7304(19)30210.
    PubMed     Text format     Abstract available


    July 2019
  64. NISHIO M, Sugawara S, Atagi S, Akamatsu H, et al
    Subgroup Analysis of Japanese Patients in a Phase III Study of Atezolizumab in Extensive-stage Small-cell Lung Cancer (IMpower133).
    Clin Lung Cancer. 2019 Jul 31. pii: S1525-7304(19)30209.
    PubMed     Text format     Abstract available


  65. GU F, Zhao C, Jiang T, Li X, et al
    Association Between Nicotine-dependent Gene Polymorphism and Smoking Cessation in Patients With Lung Cancer.
    Clin Lung Cancer. 2019 Jul 17. pii: S1525-7304(19)30206.
    PubMed     Text format     Abstract available


  66. CHENG H, Hosgood HD, Deng L, Ye K, et al
    Survival Disparities in Black Patients With EGFR-mutated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Jul 17. pii: S1525-7304(19)30207.
    PubMed     Text format     Abstract available


    June 2019
  67. SAKAKIBARA-KONISHI J, Kitai H, Ikezawa Y, Hatanaka Y, et al
    Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30172.
    PubMed     Text format    


  68. WU JY, Yu CJ, Shih JY
    Effectiveness of Treatments for Advanced Non-Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30169.
    PubMed     Text format     Abstract available


  69. SRIDHAR S, Paz-Ares L, Liu H, Shen K, et al
    Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients.
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30171.
    PubMed     Text format     Abstract available


  70. WEN J
    Comment on the data of the article titled "Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients".
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30174.
    PubMed     Text format    


  71. SCOTTI V, Bruni A, Perna M, Vasilyeva P, et al
    Response to Letter to the Editor Titled "Surgery or Stereotactic Body Radiotherapy for Early Stage Lung Cancer: What is the Current Evidence?"
    Clin Lung Cancer. 2019 Jun 19. pii: S1525-7304(19)30158.
    PubMed     Text format    


  72. GUDENKAUF LM, Clark MM, Novotny PJ, Piderman KM, et al
    Spirituality and Emotional Distress Among Lung Cancer Survivors.
    Clin Lung Cancer. 2019 Jun 19. pii: S1525-7304(19)30157.
    PubMed     Text format     Abstract available


  73. TOLWIN Y, Gillis R, Agmon IN, Shrem NS, et al
    Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening.
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30152.
    PubMed     Text format     Abstract available


  74. TIAN S, Zhang X, Jiang R, Pillai RN, et al
    Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30156.
    PubMed     Text format     Abstract available


  75. ZHAO Y, Zhang B, Wang S, Qiao R, et al
    Management of Central Nervous System Metastases in Patients With Advanced Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer During Crizotinib Treatment.
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30155.
    PubMed     Text format     Abstract available


  76. CHIARI R, Ricciuti B, Landi L, Morelli AM, et al
    ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30154.
    PubMed     Text format     Abstract available


  77. GUO D, Jin F, Jing W, Li M, et al
    Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Jun 15. pii: S1525-7304(19)30150.
    PubMed     Text format     Abstract available


  78. VAN DE KAMP HJ, Molder MT, Schulkes KJG, Stellingwerf M, et al
    Impact of Lung Cancer Treatment on Cognitive Functioning.
    Clin Lung Cancer. 2019 Jun 15. pii: S1525-7304(19)30148.
    PubMed     Text format     Abstract available


  79. UPRETY D, Arjyal L, Vallatharasu Y, Bista A, et al
    Durable Response After 2 Doses of Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer With an Isolated Brain Metastasis.
    Clin Lung Cancer. 2019 Jun 13. pii: S1525-7304(19)30144.
    PubMed     Text format    


  80. MAZZELLA A, Loi M, Mansuet-Lupo A, Bobbio A, et al
    Clinical Characteristics, Molecular Phenotyping, and Management of Isolated Adrenal Metastases From Lung Cancer.
    Clin Lung Cancer. 2019 Jun 13. pii: S1525-7304(19)30145.
    PubMed     Text format     Abstract available


  81. KAMIGAICHI A, Tsutani Y, Fujiwara M, Mimae T, et al
    Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer.
    Clin Lung Cancer. 2019 Jun 13. pii: S1525-7304(19)30146.
    PubMed     Text format     Abstract available


  82. LACOUR M, Hiltbrunner S, Lee SY, Soltermann A, et al
    Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence.
    Clin Lung Cancer. 2019 Jun 5. pii: S1525-7304(19)30140.
    PubMed     Text format     Abstract available


  83. BORKENHAGEN JF, Bergom CR, Rapp CT, Klawikowski SJ, et al
    Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.
    Clin Lung Cancer. 2019 Jun 5. pii: S1525-7304(19)30141.
    PubMed     Text format     Abstract available


    May 2019
  84. WANG S, Hao J, Qian C, Wang H, et al
    Tumor Spread Through Air Spaces Is a Survival Predictor in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 May 29. pii: S1525-7304(19)30139.
    PubMed     Text format     Abstract available


  85. JIANG Y, Liu LS, Shen LP, Liu JX, et al
    Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
    Clin Lung Cancer. 2019 May 21. pii: S1525-7304(19)30138.
    PubMed     Text format     Abstract available


  86. RAUMA V, Andersson S, Robinson EM, Rasanen JV, et al
    Thoracotomy and VATS Surgery in Local Non-Small-Cell Lung Cancer: Differences in Long-Term Health-Related Quality Of Life.
    Clin Lung Cancer. 2019 May 16. pii: S1525-7304(19)30137.
    PubMed     Text format     Abstract available


  87. TEGLASI V, Pipek O, Lozsa R, Berta K, et al
    PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis.
    Clin Lung Cancer. 2019 May 15. pii: S1525-7304(19)30112.
    PubMed     Text format     Abstract available


  88. PINSOLLE J, Mondet J, Duruisseaux M, d'Alnoncourt S, et al
    A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30105.
    PubMed     Text format    


  89. KIM R, Keam B, Hahn S, Ock CY, et al
    First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30113.
    PubMed     Text format     Abstract available


  90. IKARI T, Sakakibara-Konishi J, Yamamoto G, Kitai H, et al
    Response to First-Line Osimertinib Treatment in Non-Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30106.
    PubMed     Text format    


  91. MENDOZA DP, Stowell J, Muzikansky A, Shepard JO, et al
    Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30110.
    PubMed     Text format     Abstract available


  92. SCHILD SE, Zhao L, Wampfler JA, Daniels TB, et al
    Small-cell Lung Cancer in Very Elderly (>/= 80 Years) Patients.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30111.
    PubMed     Text format     Abstract available


  93. MARTIN J, Lehmann A, Klauschen F, Hummel M, et al
    Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 May 11. pii: S1525-7304(19)30103.
    PubMed     Text format     Abstract available


  94. CHINNIAH C, Aguarin L, Cheng P, Decesaris C, et al
    Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis.
    Clin Lung Cancer. 2019 May 4. pii: S1525-7304(19)30102.
    PubMed     Text format     Abstract available


  95. MEZQUITA L, Benito A, Ruano-Ravina A, Zamora J, et al
    Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2019 May 3. pii: S1525-7304(19)30100.
    PubMed     Text format     Abstract available


    April 2019
  96. RADES D, Motisi L, Veninga T, Conde-Moreno A, et al
    Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Apr 26. pii: S1525-7304(19)30085.
    PubMed     Text format     Abstract available


  97. ALBERTS L, Wolff HB, Kastelijn EA, Lagerwaard FJ, et al
    Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.
    Clin Lung Cancer. 2019 Apr 25. pii: S1525-7304(19)30081.
    PubMed     Text format     Abstract available


  98. SCHWARTZBERG L, Korytowsky B, Penrod JR, Zhang Y, et al
    Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy.
    Clin Lung Cancer. 2019 Apr 19. pii: S1525-7304(19)30084.
    PubMed     Text format     Abstract available


  99. DUDNIK E, Bar J, Peled N, Bshara E, et al
    Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.
    Clin Lung Cancer. 2019 Apr 5. pii: S1525-7304(19)30080.
    PubMed     Text format     Abstract available


  100. LUTFI W, Schuchert MJ, Dhupar R, Ekeke C, et al
    Node-Positive Segmentectomy for Non-Small-Cell Lung Cancer: Risk Factors and Outcomes.
    Clin Lung Cancer. 2019 Apr 1. pii: S1525-7304(19)30079.
    PubMed     Text format     Abstract available


    March 2019
  101. CHOI M, Keam B, Ock CY, Kim M, et al
    Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer.
    Clin Lung Cancer. 2019 Mar 29. pii: S1525-7304(19)30078.
    PubMed     Text format     Abstract available


  102. VOONG KR, Hazell SZ, Fu W, Hu C, et al
    Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Mar 28. pii: S1525-7304(19)30068.
    PubMed     Text format     Abstract available


  103. KOH Y, Yagi S, Akamatsu H, Kanai K, et al
    Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer.
    Clin Lung Cancer. 2019 Mar 25. pii: S1525-7304(19)30077.
    PubMed     Text format     Abstract available


  104. YU T, Shin IS, Yoon WS, Rim CH, et al
    Stereotactic Body Radiotherapy for Centrally Located Primary Non-Small-Cell Lung Cancer: A Meta-Analysis.
    Clin Lung Cancer. 2019 Mar 19. pii: S1525-7304(19)30073.
    PubMed     Text format     Abstract available


  105. LI H, Verma V, Brooks ED, Feng L, et al
    Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Mar 15. pii: S1525-7304(19)30074.
    PubMed     Text format     Abstract available


  106. VOONG KR, Liang OS, Dugan P, Torto D, et al
    Thoracic Oncology Multidisciplinary Clinic Reduces Unnecessary Health Care Expenditure Used in the Workup of Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Mar 12. pii: S1525-7304(19)30060.
    PubMed     Text format     Abstract available


  107. BUDNIK J, DeNunzio NJ, Singh DP, Milano MT, et al
    Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
    Clin Lung Cancer. 2019 Mar 4. pii: S1525-7304(19)30067.
    PubMed     Text format     Abstract available


  108. NAKAMURA M, Kageyama SI, Niho S, Okumura M, et al
    Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2019 Mar 4. pii: S1525-7304(19)30071.
    PubMed     Text format     Abstract available


  109. REN H, Hou X, Eiken PW, Zhang J, et al
    Identification and Development of a Lung Adenocarcinoma PDX Model With STRN-ALK Fusion.
    Clin Lung Cancer. 2019;20:e142-e147.
    PubMed     Text format    


  110. PASSARO A, Prelaj A, Bonanno L, Tiseo M, et al
    Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.
    Clin Lung Cancer. 2019;20:e186-e194.
    PubMed     Text format     Abstract available


  111. ROTOW JK, Woodard GA, Urisman A, McCoach CE, et al
    Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation.
    Clin Lung Cancer. 2019;20:e137-e141.
    PubMed     Text format    


  112. WU T, Zhou F, Soodeen-Lalloo AK, Yang X, et al
    The Association Between Imaging Features of TSCT and the Expression of PD-L1 in Patients With Surgical Resection of Lung Adenocarcinoma.
    Clin Lung Cancer. 2019;20:e195-e207.
    PubMed     Text format     Abstract available


  113. NIKITAS J, DeWees T, Rehman S, Abraham C, et al
    Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers.
    Clin Lung Cancer. 2019;20:107-116.
    PubMed     Text format     Abstract available


  114. CASIRAGHI M, Guarize J, Sandri A, Maisonneuve P, et al
    Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?
    Clin Lung Cancer. 2019;20:97-106.
    PubMed     Text format     Abstract available


    February 2019
  115. RICCIUTI B, Genova C, Bassanelli M, De Giglio A, et al
    Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression.
    Clin Lung Cancer. 2019 Feb 27. pii: S1525-7304(19)30020.
    PubMed     Text format     Abstract available


  116. HIRANUMA O, Uchino J, Yamada T, Chihara Y, et al
    Rationale and Design of a Phase II Trial of Osimertinib Combined With Bevacizumab in Patients With Untreated Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer and Malignant Pleural and/or Pericardial Effusion (SPIRAL II Study).
    Clin Lung Cancer. 2019 Feb 27. pii: S1525-7304(19)30066.
    PubMed     Text format     Abstract available


  117. DING M, Deng L, Yu R, Lu D, et al
    Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI-Treated Non-Small-Cell Lung Cancer Revealed Using NGS-Based Liquid Biopsy.
    Clin Lung Cancer. 2019 Feb 27. pii: S1525-7304(19)30064.
    PubMed     Text format    


  118. WINTHER-LARSEN A, Fynboe Ebert EB, Meldgaard P, Sorensen BS, et al
    EGFR Gene Polymorphism Predicts Improved Outcome in Patients With EGFR Mutation-positive Non-small cell Lung Cancer Treated With Erlotinib.
    Clin Lung Cancer. 2019 Feb 26. pii: S1525-7304(19)30061.
    PubMed     Text format     Abstract available


  119. CLAVE S, Rodon N, Pijuan L, Diaz O, et al
    Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
    Clin Lung Cancer. 2019 Feb 26. pii: S1525-7304(19)30058.
    PubMed     Text format     Abstract available


  120. WEI YF, Lim CK, Tsai MS, Huang MS, et al
    Intracranial Responses to Afatinib at Different Doses in Patients With EGFR-mutated Non-small-cell Lung Carcinoma and Brain Metastases.
    Clin Lung Cancer. 2019 Feb 26. pii: S1525-7304(19)30059.
    PubMed     Text format     Abstract available


  121. CODONY-SERVAT J, Codony-Servat C, Cardona AF, Gimenez-Capitan A, et al
    Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2019 Feb 21. pii: S1525-7304(19)30024.
    PubMed     Text format     Abstract available


  122. FELD E, Singhi EK, Phillips S, Huang LC, et al
    Palliative Care Referrals for Advanced Non-small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and Practices.
    Clin Lung Cancer. 2019 Feb 20. pii: S1525-7304(19)30021.
    PubMed     Text format     Abstract available


    January 2019
  123. PACHECO J, Bunn PA
    Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133.
    Clin Lung Cancer. 2019 Jan 2. pii: S1525-7304(18)30356.
    PubMed     Text format     Abstract available


  124. RAZ DJ, Wu G, Nelson RA, Sun V, et al
    Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program.
    Clin Lung Cancer. 2019;20:e115-e122.
    PubMed     Text format     Abstract available


  125. ZHU YC, Wang WX, Zhang QX, Xu CW, et al
    The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma.
    Clin Lung Cancer. 2019;20:e73-e76.
    PubMed     Text format    


  126. SCOTTI V, Bruni A, Francolini G, Perna M, et al
    Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
    Clin Lung Cancer. 2019;20:e53-e61.
    PubMed     Text format     Abstract available


  127. HU F, Xu J, Zhang B, Li C, et al
    Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2019;20:e81-e90.
    PubMed     Text format     Abstract available


  128. KAUFFMANN-GUERRERO D, Kahnert K, Kumbrink J, Syunyaeva Z, et al
    Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib.
    Clin Lung Cancer. 2019;20:59-62.
    PubMed     Text format    


  129. LAM VK, Tran HT, Banks KC, Lanman RB, et al
    Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations.
    Clin Lung Cancer. 2019;20:30-36.
    PubMed     Text format     Abstract available


  130. FODOR A, Broggi S, Incerti E, Dell'Oca I, et al
    Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
    Clin Lung Cancer. 2019;20:e29-e38.
    PubMed     Text format     Abstract available


    December 2018
  131. WANG B, Gao Y, Huang Y, Ou Q, et al
    Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Dec 31. pii: S1525-7304(18)30354.
    PubMed     Text format    


  132. LEE J, Sun JM, Lee SH, Ahn JS, et al
    Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor.
    Clin Lung Cancer. 2018 Dec 31. pii: S1525-7304(18)30357.
    PubMed     Text format     Abstract available


  133. NOKIHARA H, Nishio M, Yamamoto N, Fujiwara Y, et al
    Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Dec 31. pii: S1525-7304(18)30355.
    PubMed     Text format     Abstract available


  134. CERRA-FRANCO A, Liu S, Azar M, Shiue K, et al
    Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
    Clin Lung Cancer. 2018 Dec 29. pii: S1525-7304(18)30353.
    PubMed     Text format     Abstract available


  135. EZEIFE DA, Morganstein BJ, Lau S, Law JH, et al
    Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System.
    Clin Lung Cancer. 2018 Dec 22. pii: S1525-7304(18)30334.
    PubMed     Text format     Abstract available


  136. SCHWARZ M, Kocher F, Niedersuess-Beke D, Rudzki J, et al
    Immunosuppression for Immune Checkpoint-related Toxicity Can Cause Pneumocystis Jirovecii Pneumonia (PJP) in Non-small-cell Lung Cancer (NSCLC): A Report of 2 Cases.
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30330.
    PubMed     Text format    


  137. WANG L, Zhan C, Gu J, Xi J, et al
    Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non-small-cell Lung Cancer: A Propensity Score Matching Analysis.
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30331.
    PubMed     Text format     Abstract available


  138. PARK W, Lopes G
    Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30327.
    PubMed     Text format     Abstract available


  139. BEAU-FALLER M, Texier M, Blons H, Richard N, et al
    Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2).
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30336.
    PubMed     Text format     Abstract available


  140. TOMASINI P, Mascaux C, Jao K, Labbe C, et al
    Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30333.
    PubMed     Text format     Abstract available


  141. JANSSENS A, Derijcke S, Galdermans D, Daenen M, et al
    Prognostic Understanding and Quality of Life in Patients With Advanced Lung Cancer: A Multicenter Study.
    Clin Lung Cancer. 2018 Dec 13. pii: S1525-7304(18)30307.
    PubMed     Text format     Abstract available


  142. AKAMATSU H, Teraoka S, Koh Y, Yamanaka T, et al
    A Phase II Study of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L).
    Clin Lung Cancer. 2018 Dec 11. pii: S1525-7304(18)30325.
    PubMed     Text format     Abstract available


  143. JIANG T, Zhao J, Zhao C, Li X, et al
    Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Dec 4. pii: S1525-7304(18)30310.
    PubMed     Text format     Abstract available


    November 2018
  144. SAKAMOTO MR, Honce JM, Lindquist DL, Camidge DR, et al
    Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30306.
    PubMed     Text format    


  145. KWON YJ, You NY, Lee JW, Kim J, et al
    High Receipt of Statins Reduces the Risk of Lung Cancer in Current Smokers With Hypercholesterolemia: The National Health Insurance Service-Health Screening Cohort.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30305.
    PubMed     Text format     Abstract available


  146. SUZUKI R, Wei X, Allen PK, Cox JD, et al
    Prognostic Significance of Total Lymphocyte Count, Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio in Limited-stage Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30309.
    PubMed     Text format     Abstract available


  147. WHEATLEY-PRICE P, Gadgeel S, Takahashi T, Li X, et al
    Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Nov 29. pii: S1525-7304(18)30308.
    PubMed     Text format     Abstract available


  148. SONG Z, Wang H, Yu Z, Lu P, et al
    De Novo MET Amplification in Chinese Patients With Non-Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective Study.
    Clin Lung Cancer. 2018 Nov 26. pii: S1525-7304(18)30303.
    PubMed     Text format     Abstract available


  149. UPRETY D
    Chemo-immunotherapy: The Beginning of a New Era in Lung Cancer.
    Clin Lung Cancer. 2018 Nov 22. pii: S1525-7304(18)30302.
    PubMed     Text format    


  150. DALWADI SM, Lewis GD, Bernicker EH, Butler EB, et al
    Disparities in the Treatment and Outcome of Stage I Non-Small-Cell Lung Cancer in the 21st Century.
    Clin Lung Cancer. 2018 Nov 20. pii: S1525-7304(18)30300.
    PubMed     Text format     Abstract available


  151. KATSUMATA S, Aokage K, Nakasone S, Sakai T, et al
    Radiologic Criteria in Predicting Pathologic Less Invasive Lung Cancer According to TNM 8th Edition.
    Clin Lung Cancer. 2018 Nov 15. pii: S1525-7304(18)30297.
    PubMed     Text format     Abstract available


  152. ABDULLA DSY, Scheffler M, Brandes V, Ruge M, et al
    Monitoring Treatment Response to Erlotinib in EGFR-mutated Non-small-cell Lung Cancer Brain Metastases Using Serial O-(2-[(18)F]fluoroethyl)-L-tyrosine PET.
    Clin Lung Cancer. 2018 Nov 5. pii: S1525-7304(18)30295.
    PubMed     Text format    


  153. ROSSI S, Toschi L, Finocchiaro G, Di Noia V, et al
    Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Nov 2. pii: S1525-7304(18)30293.
    PubMed     Text format     Abstract available


  154. PATEL JD, Paz-Ares L, Zinner RG, Barlesi F, et al
    Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care.
    Clin Lung Cancer. 2018;19:e823-e830.
    PubMed     Text format     Abstract available


  155. XIE H, Wang H, Xu L, Li M, et al
    Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
    Clin Lung Cancer. 2018;19:484-492.
    PubMed     Text format     Abstract available


  156. SCHLEI Z, Tan W, Faber MG, Chen H, et al
    Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
    Clin Lung Cancer. 2018;19:467-475.
    PubMed     Text format     Abstract available


  157. NINOMIYA T, Ishikawa N, Inoue K, Kubo T, et al
    Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
    Clin Lung Cancer. 2018 Nov 1. pii: S1525-7304(18)30292.
    PubMed     Text format     Abstract available


    October 2018
  158. MA K, Zhan C, Wang S, Shi Y, et al
    Spread Through Air Spaces (STAS): A New Pathologic Morphology in Lung Cancer.
    Clin Lung Cancer. 2018 Oct 26. pii: S1525-7304(18)30268.
    PubMed     Text format     Abstract available


  159. HELLERSTEDT BA, Vogelzang NJ, Kluger HM, Yasenchak CA, et al
    Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non-small-cell Lung Carcinoma.
    Clin Lung Cancer. 2018 Oct 24. pii: S1525-7304(18)30267.
    PubMed     Text format     Abstract available


  160. MYALL NJ, Henry S, Wood D, Neal JW, et al
    Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 23. pii: S1525-7304(18)30264.
    PubMed     Text format     Abstract available


  161. SEYMOUR L, Le Teuff G, Brambilla E, Shepherd FA, et al
    LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30262.
    PubMed     Text format     Abstract available


  162. KIM EK, Kim KA, Lee CY, Kim S, et al
    Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30265.
    PubMed     Text format     Abstract available


  163. GRANGEON M, Tomasini P, Chaleat S, Jeanson A, et al
    Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30263.
    PubMed     Text format     Abstract available


    September 2018
  164. CHAE YK, Davis AA, Raparia K, Agte S, et al
    Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Sep 25. pii: S1525-7304(18)30253.
    PubMed     Text format     Abstract available


  165. PIRKER R, Filipits M
    Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives.
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30261.
    PubMed     Text format     Abstract available


  166. ELAMIN YY, Gomez DR, Antonoff MB, Robichaux JP, et al
    Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30260.
    PubMed     Text format     Abstract available


  167. MENG X, Gao Y, Yang L, Jing H, et al
    Immune Microenvironment Differences Between Squamous and Non-squamous Non-small-cell Lung Cancer and Their Influence on the Prognosis.
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30257.
    PubMed     Text format     Abstract available


  168. RICE SR, Molitoris JK, Vyfhuis MAL, Edelman MJ, et al
    Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis.
    Clin Lung Cancer. 2018 Sep 24. pii: S1525-7304(18)30259.
    PubMed     Text format     Abstract available


  169. KSIENSKI D, Wai ES, Croteau N, Fiorino L, et al
    Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter Analysis.
    Clin Lung Cancer. 2018 Sep 22. pii: S1525-7304(18)30250.
    PubMed     Text format     Abstract available


  170. ZHU VW, Lu Y, Ignatius Ou SH
    Severe Acute Hepatitis in a Patient Receiving Alectinib for ALK-Positive Non-Small-Cell Lung Cancer: Histologic Analysis.
    Clin Lung Cancer. 2018 Sep 21. pii: S1525-7304(18)30251.
    PubMed     Text format    


  171. SCHONEWOLF CA, Heskel M, Doucette A, Singhal S, et al
    Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
    Clin Lung Cancer. 2018 Sep 20. pii: S1525-7304(18)30237.
    PubMed     Text format     Abstract available


  172. MILLER CJ, Martin B, Stang K, Hutten R, et al
    Predictors of Distant Failure After Stereotactic Body Radiation Therapy for Stages I to IIA Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Sep 8. pii: S1525-7304(18)30235.
    PubMed     Text format     Abstract available


  173. NG TL, Yu H, Smith DE, Boyle TA, et al
    Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib.
    Clin Lung Cancer. 2018 Sep 7. pii: S1525-7304(18)30234.
    PubMed     Text format     Abstract available


  174. BERRY MF, Canchola AJ, Gensheimer MF, Gomez SL, et al
    Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
    Clin Lung Cancer. 2018;19:e745-e758.
    PubMed     Text format     Abstract available


  175. REN S, Rivard CJ, Yu H, Genova C, et al
    A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines.
    Clin Lung Cancer. 2018;19:450-456.
    PubMed     Text format     Abstract available


  176. OH IJ, Hur JY, Park CK, Kim YC, et al
    Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma.
    Clin Lung Cancer. 2018;19:e775-e781.
    PubMed     Text format     Abstract available


  177. DELANEY FT, Fong KM, Lee JC
    Incidental Pulmonary Malignancies on CTAC in MPS.
    Clin Lung Cancer. 2018;19:e801-e802.
    PubMed     Text format    


  178. TAMURA T, Ojima E, Satoh H
    Lung Cancers Detected on Computed Tomography Attenuation Correction Images During Myocardial Perfusion Scintigraphy.
    Clin Lung Cancer. 2018;19:e709.
    PubMed     Text format    


  179. RAMAN S, Yau V, Pineda S, Le LW, et al
    Ultracentral Tumors Treated With Stereotactic Body Radiotherapy: Single-Institution Experience.
    Clin Lung Cancer. 2018;19:e803-e810.
    PubMed     Text format     Abstract available


  180. VITTORIO A, Sharma R, Siejka D, Bhattarai K, et al
    Recurrent Pericardial Effusion While Receiving Nivolumab for Metastatic Lung Adenocarcinoma: Case Report and Review of the Literature.
    Clin Lung Cancer. 2018;19:e717-e720.
    PubMed     Text format    


  181. ANDERSSON S, Ilonen I, Jarvinen T, Rauma V, et al
    Surgically Treated Unsuspected N2-Positive NSCLC: Role of Extent and Location of Lymph Node Metastasis.
    Clin Lung Cancer. 2018;19:418-425.
    PubMed     Text format     Abstract available


  182. MATSUOKA H, Kimura H, Koba H, Tambo Y, et al
    Nivolumab-induced Limbic Encephalitis with Anti-Hu Antibody in a Patient With Advanced Pleomorphic Carcinoma of the Lung.
    Clin Lung Cancer. 2018;19:e597-e599.
    PubMed     Text format    


  183. FUJIMOTO N, Aoe K, Kozuki T, Oze I, et al
    A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol.
    Clin Lung Cancer. 2018;19:e705-e707.
    PubMed     Text format     Abstract available


  184. ZHANG C, Li F, Li J, Xu Y, et al
    Docetaxel Down-Regulates PD-1 Expression via STAT3 in T Lymphocytes.
    Clin Lung Cancer. 2018;19:e675-e683.
    PubMed     Text format     Abstract available


  185. SHAABAN SG, Verma V, Choi JI, Shabason J, et al
    Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.
    Clin Lung Cancer. 2018;19:e685-e692.
    PubMed     Text format     Abstract available


    August 2018
  186. AKAMATSU H, Harada H, Tokunaga S, Yoshimura N, et al
    A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non-small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L).
    Clin Lung Cancer. 2018 Aug 30. pii: S1525-7304(18)30230.
    PubMed     Text format     Abstract available


  187. KIM E, Wu HG, Keam B, Kim TM, et al
    Significance of (18)F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non-small-cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
    Clin Lung Cancer. 2018 Aug 30. pii: S1525-7304(18)30231.
    PubMed     Text format     Abstract available


  188. GRASS GD, Naghavi AO, Abuodeh YA, Perez BA, et al
    Analysis of Relapse Events After Definitive Chemoradiotherapy in Locally Advanced Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2018 Aug 29. pii: S1525-7304(18)30203.
    PubMed     Text format     Abstract available


  189. WU F, Lin X, Yang Z, Sun Z, et al
    Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer.
    Clin Lung Cancer. 2018 Aug 23. pii: S1525-7304(18)30200.
    PubMed     Text format     Abstract available


  190. ZHAO X, Feng Z, Wang G, Pang H, et al
    Ceritinib Alone for Crizotinib-naive Versus Crizotinib-pretreated for Management of Anaplastic Lymphoma Kinase-rearrangement Non-Small-cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2018 Aug 23. pii: S1525-7304(18)30207.
    PubMed     Text format     Abstract available


  191. YU TM, Morrison C, Gold EJ, Tradonsky A, et al
    Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non-Small-cell Lung Cancer: A Single-center Analysis.
    Clin Lung Cancer. 2018 Aug 23. pii: S1525-7304(18)30204.
    PubMed     Text format     Abstract available


  192. WAINER Z, Wright GM, Gough K, Daniels MG, et al
    Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30198.
    PubMed     Text format     Abstract available


  193. SUZUKI R, Wei X, Allen PK, Welsh JW, et al
    Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30206.
    PubMed     Text format     Abstract available


  194. IAMS WT, Yu H, Shyr Y, Patil T, et al
    First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30205.
    PubMed     Text format     Abstract available


  195. OWEN DH, Wei L, Bertino EM, Edd T, et al
    Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30202.
    PubMed     Text format     Abstract available


  196. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30209.
    PubMed     Text format     Abstract available


  197. RENAUD S, Guerrera F, Seitlinger J, Reeb J, et al
    KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Aug 22. pii: S1525-7304(18)30199.
    PubMed     Text format     Abstract available


  198. HATA A, Katakami N, Shimokawa M, Mitsudomi T, et al
    Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).
    Clin Lung Cancer. 2018 Aug 7. pii: S1525-7304(18)30193.
    PubMed     Text format     Abstract available


  199. BARBIE DA, Spira A, Kelly K, Humeniuk R, et al
    Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure.
    Clin Lung Cancer. 2018 Aug 4. pii: S1525-7304(18)30171.
    PubMed     Text format     Abstract available


    July 2018
  200. CUMMINGS MA, Ma SJ, Hermann G, Serra L, et al
    Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-small-cell Lung Cancer: A Two-institution Propensity-matched Analysis.
    Clin Lung Cancer. 2018 Jul 30. pii: S1525-7304(18)30190.
    PubMed     Text format     Abstract available


  201. IIJIMA Y, Hirotsu Y, Mochizuki H, Amemiya K, et al
    Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Jul 26. pii: S1525-7304(18)30169.
    PubMed     Text format    


  202. VERMA V, Schonewolf CA, Cushman TR, Post CM, et al
    Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Jul 25. pii: S1525-7304(18)30172.
    PubMed     Text format     Abstract available


  203. DRIESSEN EJM, Janssen-Heijnen MLG, Maas HA, Dingemans AC, et al
    Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Jul 9. pii: S1525-7304(18)30170.
    PubMed     Text format     Abstract available


  204. WU YL, Herbst RS, Mann H, Rukazenkov Y, et al
    ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.
    Clin Lung Cancer. 2018;19:e533-e536.
    PubMed     Text format     Abstract available


    June 2018
  205. CHANG H, Yang Y, Lee JS, Jheon SH, et al
    Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer.
    Clin Lung Cancer. 2018 Jun 27. pii: S1525-7304(18)30162.
    PubMed     Text format     Abstract available


  206. WU F, Zhang S, Xiong A, Gao G, et al
    A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Jun 27. pii: S1525-7304(18)30161.
    PubMed     Text format     Abstract available


  207. RAGHAVAN G, Shaverdian N, Chan S, Chu FI, et al
    Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.
    Clin Lung Cancer. 2018 Jun 6. pii: S1525-7304(18)30128.
    PubMed     Text format     Abstract available


  208. ARUNACHALAM A, Li H, Bittoni MA, Camacho R, et al
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Jun 6. pii: S1525-7304(18)30136.
    PubMed     Text format     Abstract available


  209. LEE A, Howell VM, Itchins M, Wheeler HR, et al
    ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.
    Clin Lung Cancer. 2018 Jun 5. pii: S1525-7304(18)30135.
    PubMed     Text format    


  210. SU CT, Bhargava A, Shah CD, Halmos B, et al
    Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
    Clin Lung Cancer. 2018 Jun 5. pii: S1525-7304(18)30139.
    PubMed     Text format     Abstract available


    May 2018
  211. PAOLINI D, Tiseo M, Demma F, Furneri G, et al
    Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non-Small-cell Lung Cancer: Clinical and Budget Effect.
    Clin Lung Cancer. 2018 May 31. pii: S1525-7304(18)30132.
    PubMed     Text format     Abstract available


  212. BORDONI R, Ciardiello F, von Pawel J, Cortinovis D, et al
    Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 31. pii: S1525-7304(18)30131.
    PubMed     Text format     Abstract available


  213. KAWACHI H, Fujimoto D, Morimoto T, Ito M, et al
    Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials.
    Clin Lung Cancer. 2018 May 26. pii: S1525-7304(18)30134.
    PubMed     Text format     Abstract available


  214. KOGURE Y, Saka H, Takiguchi Y, Atagi S, et al
    A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.
    Clin Lung Cancer. 2018 May 19. pii: S1525-7304(18)30110.
    PubMed     Text format     Abstract available


  215. RAMAN S, Bissonnette JP, Warner A, Le L, et al
    Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-small-cell Lung Cancer (NCT02788461).
    Clin Lung Cancer. 2018 May 16. pii: S1525-7304(18)30107.
    PubMed     Text format     Abstract available


  216. RODRIGUEZ DE DIOS N, Counago F, Lopez JL, Calvo P, et al
    Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radia
    Clin Lung Cancer. 2018 May 10. pii: S1525-7304(18)30108.
    PubMed     Text format     Abstract available


  217. SAIKI M, Kitazono S, Yoshizawa T, Dotsu Y, et al
    Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.
    Clin Lung Cancer. 2018 May 10. pii: S1525-7304(18)30088.
    PubMed     Text format     Abstract available


  218. ZER A, Sung MR, Walia P, Khoja L, et al
    Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 May 8. pii: S1525-7304(18)30090.
    PubMed     Text format     Abstract available


  219. LOONG HH, Raymond VM, Shiotsu Y, Chua DTT, et al
    Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30104.
    PubMed     Text format     Abstract available


  220. BITTONI MA, Arunachalam A, Li H, Camacho R, et al
    Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30099.
    PubMed     Text format     Abstract available


  221. HIRSH V, Wan Y, Lin FJ, Margunato-Debay S, et al
    Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin.
    Clin Lung Cancer. 2018 May 7. pii: S1525-7304(18)30105.
    PubMed     Text format     Abstract available


  222. FUJIMOTO D, Sato Y, Morimoto T, Uehara K, et al
    Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30094.
    PubMed     Text format     Abstract available


  223. FUKUI T, Okuma Y, Nakahara Y, Otani S, et al
    Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30103.
    PubMed     Text format     Abstract available


  224. GINESTET F, Lambros L, Le Flahec G, Marcorelles P, et al
    Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30098.
    PubMed     Text format     Abstract available


  225. FACCHINETTI F, Gnetti L, Caruana P, Fornaroli F, et al
    Widespread Nivolumab-induced Enteropathy in a Long Responder Non-Small-cell Lung Cancer Patient.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30095.
    PubMed     Text format    


  226. LAMBROS L, Uguen A
    Toward a Molecular Diagnosis in a Single Day for Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30044.
    PubMed     Text format    


  227. OKUMA Y, Wakui H, Utsumi H, Sagawa Y, et al
    Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30096.
    PubMed     Text format     Abstract available


  228. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30089.
    PubMed     Text format     Abstract available


  229. ATAGI S, Mizusawa J, Ishikura S, Takahashi T, et al
    Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).
    Clin Lung Cancer. 2018 May 5. pii: S1525-7304(18)30100.
    PubMed     Text format     Abstract available


  230. VANDERLAAN PA, Chen Y, DiStasio M, Rangachari D, et al
    Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target.
    Clin Lung Cancer. 2018 May 4. pii: S1525-7304(18)30087.
    PubMed     Text format    


    April 2018
  231. CHIN AL, Kumar KA, Guo HH, Maxim PG, et al
    Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Apr 19. pii: S1525-7304(18)30085.
    PubMed     Text format     Abstract available


  232. GIULIANI M, Mathew AS, Bahig H, Bratman SV, et al
    SUNSET: Stereotactic Radiation for Ultracentral Non-Small-Cell Lung Cancer-A Safety and Efficacy Trial.
    Clin Lung Cancer. 2018 Apr 18. pii: S1525-7304(18)30073.
    PubMed     Text format     Abstract available


    March 2018
  233. PAXIMADIS P, Beebe-Dimmer JL, George J, Schwartz AG, et al
    Comparing Treatment Strategies for Stage I Small-cell lung Cancer.
    Clin Lung Cancer. 2018 Mar 23. pii: S1525-7304(18)30059.
    PubMed     Text format     Abstract available


  234. GIACCONE G, Sanborn RE, Waqar SN, Martinez-Marti A, et al
    A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation.
    Clin Lung Cancer. 2018 Mar 23. pii: S1525-7304(18)30058.
    PubMed     Text format     Abstract available


  235. HIRSCH FR, Kerr KM, Bunn PA Jr, Kim ES, et al
    Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
    Clin Lung Cancer. 2018 Mar 21. pii: S1525-7304(18)30056.
    PubMed     Text format     Abstract available


  236. WU YL, Sequist LV, Tan EH, Geater SL, et al
    Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30051.
    PubMed     Text format     Abstract available


  237. REIS H, Metzenmacher M, Goetz M, Savvidou N, et al
    MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30052.
    PubMed     Text format     Abstract available


  238. GRILLEY-OLSON JE, Weiss J, Ivanova A, Villaruz LC, et al
    Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30050.
    PubMed     Text format     Abstract available


  239. TOH CK, Ong WS, Lim WT, Tan DS, et al
    A Decade of Never-smokers Among Lung Cancer Patients-Increasing Trend and Improved Survival.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30055.
    PubMed     Text format     Abstract available


  240. KIM CR, Kim B, Ning MS, Reddy JP, et al
    Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30054.
    PubMed     Text format     Abstract available


  241. VISSER S, de Mol M, Cheung K, van Toor JJ, et al
    Treatment Satisfaction of Patients With Advanced Non-Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL).
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30045.
    PubMed     Text format     Abstract available


  242. DEEK MP, Kim S, Beck R, Yegya-Raman N, et al
    Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non-Small Cell Lung Cancer Are Associated With Decreases in Overall Survival.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30049.
    PubMed     Text format     Abstract available


  243. ARDESHIR-LARIJANI F, Bhateja P, Lipka MB, Sharma N, et al
    KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Mar 16. pii: S1525-7304(18)30047.
    PubMed     Text format     Abstract available


  244. SIO TT, Prayongrat A, Zhang Y, Lin Q, et al
    The Road Less Traveled: Should We Omit Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer?
    Clin Lung Cancer. 2018 Mar 16. pii: S1525-7304(18)30048.
    PubMed     Text format     Abstract available


  245. WAQAR SN, Samson PP, Robinson CG, Bradley J, et al
    Non-small-cell Lung Cancer With Brain Metastasis at Presentation.
    Clin Lung Cancer. 2018 Mar 8. pii: S1525-7304(18)30019.
    PubMed     Text format     Abstract available


    February 2018
  246. FARRELL MJ, Yahya JB, Degnin C, Chen Y, et al
    Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Clin Lung Cancer. 2018 Feb 23. pii: S1525-7304(18)30042.
    PubMed     Text format     Abstract available


  247. PETRELLI F, Maltese M, Tomasello G, Conti B, et al
    Clinical and Molecular Predictors of PD-L1 Expression in Non-Small-Cell Lung Cancer: Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2018 Feb 21. pii: S1525-7304(18)30025.
    PubMed     Text format     Abstract available


  248. STONE CJL, Vaid HM, Selvam R, Ashworth A, et al
    Multidisciplinary Clinics in Lung Cancer Care: A Systematic Review.
    Clin Lung Cancer. 2018 Feb 21. pii: S1525-7304(18)30020.
    PubMed     Text format     Abstract available


  249. TAKASHIMA Y, Sakakibara-Konishi J, Hatanaka Y, Hatanaka KC, et al
    Clinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    Clin Lung Cancer. 2018 Feb 19. pii: S1525-7304(18)30023.
    PubMed     Text format     Abstract available


  250. NADLER E, Espirito JL, Pavilack M, Boyd M, et al
    Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small-Cell Lung Cancer Patients Treated in the Community Practice Setting.
    Clin Lung Cancer. 2018 Feb 17. pii: S1525-7304(18)30021.
    PubMed     Text format     Abstract available


  251. WU TH, Hsiue EH, Lee JH, Lin CC, et al
    Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30017.
    PubMed     Text format     Abstract available


  252. BILFINGER TV, Albano D, Perwaiz M, Keresztes R, et al
    Survival Outcomes Among Lung Cancer Patients Treated Using a Multidisciplinary Team Approach.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30018.
    PubMed     Text format     Abstract available


  253. HIDA T, Kaji R, Satouchi M, Ikeda N, et al
    Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.
    Clin Lung Cancer. 2018 Feb 1. pii: S1525-7304(18)30016.
    PubMed     Text format     Abstract available


    January 2018
  254. KHUNGER M, Jain P, Rakshit S, Pasupuleti V, et al
    Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2018 Jan 10. pii: S1525-7304(18)30002.
    PubMed     Text format     Abstract available


  255. KOBAYASHI K, Nakachi I, Naoki K, Satomi R, et al
    Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis.
    Clin Lung Cancer. 2018 Jan 5. pii: S1525-7304(18)30001.
    PubMed     Text format     Abstract available


  256. ZHENG Y, Shi A, Wang W, Yu H, et al
    Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
    Clin Lung Cancer. 2018 Jan 4. pii: S1525-7304(17)30351.
    PubMed     Text format     Abstract available


  257. TAMURA T, Miyazaki K, Shiozawa T, Satoh H, et al
    Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxol-based Chemotherapy for Stage IV NSCLC.
    Clin Lung Cancer. 2018;19:e67.
    PubMed     Text format    


    December 2017
  258. GRIDELLI C, Baas P, Barlesi F, Ciardiello F, et al
    Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.
    Clin Lung Cancer. 2017 Dec 22. pii: S1525-7304(17)30349.
    PubMed     Text format     Abstract available


  259. QIU T, Li W, Zhang T, Xing P, et al
    Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30345.
    PubMed     Text format     Abstract available


  260. PARK W, Kwon D, Saravia D, Desai A, et al
    Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30346.
    PubMed     Text format     Abstract available


  261. RAMALINGAM SS, Perol M, Reck M, Kowalyszyn RD, et al
    Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30350.
    PubMed     Text format     Abstract available


  262. BERNHARDT D, Konig L, Aufderstrasse S, Krisam J, et al
    Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
    Clin Lung Cancer. 2017 Dec 15. pii: S1525-7304(17)30343.
    PubMed     Text format     Abstract available


  263. SHARMA S, McMillan MT, Doucette A, Cohen RB, et al
    Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
    Clin Lung Cancer. 2017 Dec 14. pii: S1525-7304(17)30342.
    PubMed     Text format     Abstract available


  264. SALEM A, Mistry H, Backen A, Hodgson C, et al
    Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging.
    Clin Lung Cancer. 2017 Dec 11. pii: S1525-7304(17)30341.
    PubMed     Text format     Abstract available


  265. HALD SM, Rakaee M, Martinez I, Richardsen E, et al
    LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival.
    Clin Lung Cancer. 2017 Dec 11. pii: S1525-7304(17)30340.
    PubMed     Text format     Abstract available


  266. STOY SP, Segal JP, Mueller J, Furtado LV, et al
    Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Dec 5. pii: S1525-7304(17)30322.
    PubMed     Text format     Abstract available


    November 2017
  267. MA SJ, Cummings M, Serra LM, Syed YA, et al
    Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Two-Institution Propensity Score-Matched Analysis.
    Clin Lung Cancer. 2017 Nov 26. pii: S1525-7304(17)30319.
    PubMed     Text format     Abstract available


  268. DALWADI SM, Szeja SS, Bernicker EH, Butler EB, et al
    Practice Patterns and Outcomes in Elderly Stage I Non-Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30316.
    PubMed     Text format     Abstract available


  269. DAMHUIS RAM, Senan S, Belderbos JS
    Usage of Prophylactic Cranial Irradiation in Elderly Patients With Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30317.
    PubMed     Text format     Abstract available


  270. MASSABEAU C, Khalifa J, Filleron T, Modesto A, et al
    Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30314.
    PubMed     Text format     Abstract available


  271. RECK M, Garon EB, Paz-Ares L, Ponce S, et al
    Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results.
    Clin Lung Cancer. 2017 Nov 21. pii: S1525-7304(17)30315.
    PubMed     Text format     Abstract available


  272. SURA K, Grills IS, Vu CC, Stevens CW, et al
    Improved Survival With Increased Time-To-Radiation and Sequential Chemotherapy After Surgery for pN2 Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 17. pii: S1525-7304(17)30305.
    PubMed     Text format     Abstract available


  273. LEE S, Song SY, Kim SS, Choi W, et al
    Feasible Optimization of Stereotactic Ablative Radiotherapy Dose by Tumor Size for Stage I Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 14. pii: S1525-7304(17)30313.
    PubMed     Text format     Abstract available


  274. JIANG T, Liu H, Qiao M, Li X, et al
    Impact of Clinicopathologic Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients With Previously Treated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Nov 9. pii: S1525-7304(17)30312.
    PubMed     Text format     Abstract available


    October 2017
  275. NAKAMURA H, Koizumi H, Sakai H, Kimura H, et al
    Accuracy of the cobas EGFR Mutation Assay in Non-small-cell Lung Cancer Compared With Three Laboratory-developed Tests.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30309.
    PubMed     Text format     Abstract available


  276. GOBBINI E, Pilotto S, Pasello G, Polo V, et al
    Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30306.
    PubMed     Text format     Abstract available


  277. ZHOU H, Zhang Y, Qiu Z, Chen G, et al
    Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30310.
    PubMed     Text format     Abstract available


  278. TAKADA K, Toyokawa G, Shoji F, Okamoto T, et al
    The Significance of the PD-L1 Expression in Non-Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30308.
    PubMed     Text format     Abstract available


  279. MA SJ, Serra LM, Syed YA, Hermann GM, et al
    Comparison of Single- and Three-fraction Schedules of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30304.
    PubMed     Text format     Abstract available


  280. JOHNSON DY, Short RG, Patz EF Jr
    Sequential CT Findings in Patients With Non-small-cell Lung Cancer Receiving Nivolumab.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30303.
    PubMed     Text format     Abstract available


  281. PELLEGRINO B, Facchinetti F, Bordi P, Silva M, et al
    Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30302.
    PubMed     Text format     Abstract available


  282. ITO K, Suzuki Y, Saiki H, Sakaguchi T, et al
    Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non-Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30311.
    PubMed     Text format     Abstract available


  283. CUPP J, Culakova E, Poniewierski MS, Dale DC, et al
    Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia.
    Clin Lung Cancer. 2017 Oct 28. pii: S1525-7304(17)30307.
    PubMed     Text format     Abstract available


  284. AGGARWAL C, Cohen RB, Yu E, Hwang WT, et al
    Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study.
    Clin Lung Cancer. 2017 Oct 19. pii: S1525-7304(17)30281.
    PubMed     Text format     Abstract available


  285. INOUE T, Tamiya M, Tamiya A, Nakahama K, et al
    Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab.
    Clin Lung Cancer. 2017 Oct 13. pii: S1525-7304(17)30274.
    PubMed     Text format     Abstract available


  286. CIULEANU T, Socinski MA, Obasaju C, Luft AV, et al
    Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Oct 13. pii: S1525-7304(17)30278.
    PubMed     Text format     Abstract available


  287. KESARWALA AH, Lu DJ, Xanthopoulos E, Apisarnthanarax S, et al
    The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Oct 12. pii: S1525-7304(17)30275.
    PubMed     Text format     Abstract available


    September 2017
  288. MA L, Ye W, Li Q, Wang B, et al
    Subjective Global Assessment (SGA) Score Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients With Normal Pulmonary Function Treated by Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy.
    Clin Lung Cancer. 2017 Sep 19. pii: S1525-7304(17)30259.
    PubMed     Text format     Abstract available


  289. LANGER CJ, Paz-Ares LG, Wozniak AJ, Gridelli C, et al
    Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.
    Clin Lung Cancer. 2017;18:489-496.
    PubMed     Text format     Abstract available


  290. REMON J, Menis J, Hasan B, Peric A, et al
    The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613.
    Clin Lung Cancer. 2017;18:583-588.
    PubMed     Text format     Abstract available


  291. TOYOKAWA G, Takada K, Okamoto T, Kozuma Y, et al
    High Frequency of Programmed Death-ligand 1 Expression in Emphysematous Bullae-associated Lung Adenocarcinomas.
    Clin Lung Cancer. 2017;18:504-511.
    PubMed     Text format     Abstract available


  292. GIRARD P, Caliandro R, Seguin-Givelet A, Lenoir S, et al
    Sensitivity of Cytology Specimens From Bronchial Aspirate or Washing During Bronchoscopy in the Diagnosis of Lung Malignancies: An Update.
    Clin Lung Cancer. 2017;18:512-518.
    PubMed     Text format     Abstract available


    August 2017
  293. AKTHAR AS, Koshy M, Ferguson MK, Murgu S, et al
    Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy.
    Clin Lung Cancer. 2017 Aug 31. pii: S1525-7304(17)30231.
    PubMed     Text format     Abstract available


  294. HALTHORE A, Goenka A, Sharma R, Knisely JPS, et al
    Prophylactic Cranial Irradiation for Resectable Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Aug 26. pii: S1525-7304(17)30232.
    PubMed     Text format     Abstract available


  295. KIM E, Feldman R, Wistuba II
    Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Aug 12. pii: S1525-7304(17)30229.
    PubMed     Text format     Abstract available


  296. KAWAMURA T, Kenmotsu H, Omori S, Nakashima K, et al
    Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Aug 10. pii: S1525-7304(17)30210.
    PubMed     Text format     Abstract available


  297. BROSSEAU S, Gounant V, Naltet C, Theou-Anton N, et al
    Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation.
    Clin Lung Cancer. 2017 Aug 3. pii: S1525-7304(17)30211.
    PubMed     Text format    


    July 2017
  298. ALEXANDER M, Solomon B, Burbury K
    Thromboembolism in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Jul 22. pii: S1525-7304(17)30209.
    PubMed     Text format    


  299. ABUODEH Y, Naghavi AO, Echevarria M, DeMarco M, et al
    Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis.
    Clin Lung Cancer. 2017 Jul 8. pii: S1525-7304(17)30196.
    PubMed     Text format     Abstract available


  300. VERMA V, Simone CB 2nd
    Surgery Versus Conventional Radiation Therapy for T1-2 N0 M0 Small-cell Lung Cancer: A Fair Comparison?
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30201.
    PubMed     Text format    


  301. YANG JC, Mok T, Han B, Orlando M, et al
    A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30200.
    PubMed     Text format     Abstract available


  302. TAKAMORI S, Toyokawa G, Takada K, Shoji F, et al
    Combination Therapy of Radiotherapy and Anti-PD-1/PD-L1 Treatment in Non-Small-cell Lung Cancer: A Mini-review.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30202.
    PubMed     Text format     Abstract available


  303. SONNICK MA, Oro F, Yan B, Desai A, et al
    Identifying the Optimal Radiation Dose in Locally Advanced Non-Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent Chemotherapy.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30206.
    PubMed     Text format     Abstract available


  304. WEST HL, Moon J, Wozniak AJ, Mack P, et al
    Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials.
    Clin Lung Cancer. 2017 Jul 6. pii: S1525-7304(17)30203.
    PubMed     Text format     Abstract available


    June 2017
  305. QIAO M, Jiang T, Ren S, Zhou C, et al
    Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?
    Clin Lung Cancer. 2017 Jun 23. pii: S1525-7304(17)30178.
    PubMed     Text format     Abstract available


  306. ZUGAZAGOITIA J, Rueda D, Carrizo N, Enguita AB, et al
    Prospective Clinical Integration of an Amplicon-Based Next-Generation Sequencing Method to Select Advanced Non-Small-Cell Lung Cancer Patients for Genotype-Tailored Treatments.
    Clin Lung Cancer. 2017 Jun 23. pii: S1525-7304(17)30181.
    PubMed     Text format     Abstract available


  307. JIN F, Qu B, Fu Z, Zhang Y, et al
    Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on 18F-FDG PET/CT in Patients With Limited-stage Small-cell Lung Cancer With Lymph Node Involvement.
    Clin Lung Cancer. 2017 Jun 22. pii: S1525-7304(17)30179.
    PubMed     Text format     Abstract available


  308. DUDANI S, Zhu X, Yokom DW, Yamada A, et al
    Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes.
    Clin Lung Cancer. 2017 Jun 21. pii: S1525-7304(17)30180.
    PubMed     Text format     Abstract available


  309. OTSUBO K, Kishimoto J, Kenmotsu H, Minegishi Y, et al
    Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.
    Clin Lung Cancer. 2017 Jun 20. pii: S1525-7304(17)30176.
    PubMed     Text format     Abstract available


  310. GAUT D, Sim MS, Yue Y, Wolf BR, et al
    Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2017 Jun 20. pii: S1525-7304(17)30177.
    PubMed     Text format     Abstract available


  311. NOMA D, Inamura K, Matsuura Y, Hirata Y, et al
    Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Jun 20. pii: S1525-7304(17)30174.
    PubMed     Text format     Abstract available


  312. KALMAN NS, Weiss E, Walker PR, Rosenman JG, et al
    Local Radiotherapy Intensification for Locally Advanced Non-small-cell Lung Cancer - A Call to Arms.
    Clin Lung Cancer. 2017 Jun 16. pii: S1525-7304(17)30173.
    PubMed     Text format     Abstract available


  313. MCGEE SF, Zhang T, Jonker H, Laurie SA, et al
    The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30167.
    PubMed     Text format     Abstract available


  314. UMAKOSHI H, Iwano S, Yokoi K, Ito S, et al
    FDG PET/CT Overcomes Discordance Between Clinical and Pathologic TNM Classification of Small-size Primary Lung Cancer: Influence on Postoperative Prognosis.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30170.
    PubMed     Text format     Abstract available


  315. YAMAMOTO N, Kenmotsu H, Yamanaka T, Nakamura S, et al
    Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non-Small-Cell Lung Cancer: The JIPANG Study Protocol.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30169.
    PubMed     Text format     Abstract available


  316. PILOTTO S, Rossi A, Vavala T, Follador A, et al
    Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30165.
    PubMed     Text format     Abstract available


  317. RAZ DJ, Wu GX, Consunji M, Nelson RA, et al
    The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30148.
    PubMed     Text format     Abstract available


  318. SADOYAMA S, Sekine A, Satoh H, Iwasawa T, et al
    Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non-Small-Cell Lung Cancer Patients With an EGFR Mutation.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30166.
    PubMed     Text format     Abstract available


    May 2017
  319. WOODARD GA, Wang SX, Kratz JR, Zoon-Besselink CT, et al
    Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 May 31. pii: S1525-7304(17)30150.
    PubMed     Text format     Abstract available


  320. HAYASHI H, Chiba Y, Sakai K, Fujita T, et al
    A Randomized Phase II Study Comparing Nivolumab With Carboplatin-Pemetrexed for Patients With EGFR Mutation-Positive Nonsquamous Non-Small-Cell Lung Cancer Who Acquire Resistance to Tyrosine Kinase Inhibitors Not Due to a Secondary T790M Mutation: Rat
    Clin Lung Cancer. 2017 May 25. pii: S1525-7304(17)30147.
    PubMed     Text format     Abstract available


  321. WANG X, Yan S, Lv C, Wang Y, et al
    Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.
    Clin Lung Cancer. 2017 May 11. pii: S1525-7304(17)30136.
    PubMed     Text format     Abstract available


  322. FRELINGHUYSEN M, Fest J, Van der Voort Van Zyp NC, Van der Holt B, et al
    Consequences of Referral Time and Volume Doubling Time in Inoperable Patients With Early Stage Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30137.
    PubMed     Text format     Abstract available


  323. SHIN JY, Yoon JK, Marwaha G
    External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non-Small Cell Lung Cancer Patients With
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30144.
    PubMed     Text format     Abstract available


  324. NAKAMICHI S, Horinouchi H, Asao T, Goto Y, et al
    Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30140.
    PubMed     Text format     Abstract available


  325. YOKOTA H, Sato K, Okuda Y, Kobayashi H, et al
    Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30145.
    PubMed     Text format     Abstract available


  326. KATO R, Hayashi H, Chiba Y, Tanaka K, et al
    Prognostic Impact of Minimal Pericardial Effusion in Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30146.
    PubMed     Text format     Abstract available


  327. LEONG TL, Christie M, Kranz S, Pham K, et al
    Evaluating the Genomic Yield of a Single Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in Lung Cancer: Meeting the Challenge of Doing More With Less.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30141.
    PubMed     Text format     Abstract available


  328. GLISSON B, Besse B, Dols MC, Dubey S, et al
    A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30142.
    PubMed     Text format     Abstract available


  329. RAJUPET S, Doshi D, Wisnivesky JP, Lin JJ, et al
    Attitudes About Lung Cancer Screening: Primary Care Providers Versus Specialists.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30138.
    PubMed     Text format     Abstract available


  330. GARCIA S, Saltarski JM, Yan J, Xie XJ, et al
    Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical Trials.
    Clin Lung Cancer. 2017 May 8. pii: S1525-7304(17)30132.
    PubMed     Text format     Abstract available


  331. WU AJ, Garay E, Foster A, Hsu M, et al
    Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery.
    Clin Lung Cancer. 2017;18:e161-e168.
    PubMed     Text format     Abstract available


  332. SUN V, Raz DJ, Ruel N, Chang W, et al
    A Multimedia Self-management Intervention to Prepare Cancer Patients and Family Caregivers for Lung Surgery and Postoperative Recovery.
    Clin Lung Cancer. 2017;18:e151-e159.
    PubMed     Text format     Abstract available


    April 2017
  333. AHMED HZ, Liu Y, O'Connell K, Ahmed MZ, et al
    Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
    Clin Lung Cancer. 2017 Apr 28. pii: S1525-7304(17)30114.
    PubMed     Text format     Abstract available


  334. GANTI AK, Hirsch FR, Wynes MW, Ravelo A, et al
    Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer.
    Clin Lung Cancer. 2017 Apr 26. pii: S1525-7304(17)30115.
    PubMed     Text format     Abstract available


  335. FENSKE DC, Price GL, Hess LM, John WJ, et al
    Systematic Review of Brain Metastases in Patients With Non-Small-Cell Lung Cancer in the United States, European Union, and Japan.
    Clin Lung Cancer. 2017 Apr 26. pii: S1525-7304(17)30116.
    PubMed     Text format     Abstract available


  336. CHO JH, Sorensen SF, Choi YL, Feng Y, et al
    Programmed Death Ligand 1 Expression in Paired Non-Small Cell Lung Cancer Tumor Samples.
    Clin Lung Cancer. 2017 Apr 24. pii: S1525-7304(17)30113.
    PubMed     Text format     Abstract available


  337. DAHELE M, Damhuis RA
    Relationship Between Tumor Location and Outcome in Patients With Early-Stage Lung Cancer.
    Clin Lung Cancer. 2017 Apr 23. pii: S1525-7304(17)30110.
    PubMed     Text format    


  338. GIULIANI J, Bonetti A
    Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs.
    Clin Lung Cancer. 2017 Apr 23. pii: S1525-7304(17)30112.
    PubMed     Text format    


  339. GUTIERREZ ME, Choi K, Lanman RB, Licitra EJ, et al
    Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.
    Clin Lung Cancer. 2017 Apr 13. pii: S1525-7304(17)30109.
    PubMed     Text format     Abstract available


  340. QIU B, Liang Y, Li Q, Liu G, et al
    Local Therapy for Oligoprogressive Disease in Patients With Advanced Stage Non-small-cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation.
    Clin Lung Cancer. 2017 Apr 12. pii: S1525-7304(17)30107.
    PubMed     Text format     Abstract available


  341. CHEN K, Chen H, Yang F, Sui X, et al
    Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Apr 12. pii: S1525-7304(17)30106.
    PubMed     Text format     Abstract available


    March 2017
  342. AHMED Z, Kujtan L, Kennedy KF, Davis JR, et al
    Disparities in the Management of Patients With Stage I Small Cell Lung Carcinoma (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Clin Lung Cancer. 2017 Mar 30. pii: S1525-7304(17)30080.
    PubMed     Text format     Abstract available


  343. SAKAMOTO S, Yamada T, Terazaki Y, Yoshiyama K, et al
    Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 24. pii: S1525-7304(17)30088.
    PubMed     Text format     Abstract available


  344. BATTISTI NML, Sehovic M, Extermann M
    Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older.
    Clin Lung Cancer. 2017 Mar 21. pii: S1525-7304(17)30082.
    PubMed     Text format     Abstract available


  345. VERMA V, Rwigema JM, Adeberg S, Simone CB 2nd, et al
    Enrollment of Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer in Multi-institutional Trials of Proton Beam Radiation Therapy.
    Clin Lung Cancer. 2017 Mar 16. pii: S1525-7304(17)30084.
    PubMed     Text format    


  346. CASSIDY RJ, Patel PR, Zhang X, Press RH, et al
    Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.
    Clin Lung Cancer. 2017 Mar 16. pii: S1525-7304(17)30083.
    PubMed     Text format     Abstract available


  347. JUAN O, Popat S
    Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30079.
    PubMed     Text format     Abstract available


  348. DISTASIO M, Chen Y, Rangachari D, Costa DB, et al
    Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30078.
    PubMed     Text format     Abstract available


  349. YONEDA KY, Scranton JR, Cadogan MA, Tassell V, et al
    Interstitial Lung Disease Associated With Crizotinib in Patients With Advanced Non-Small Cell Lung Cancer: Independent Review of Four PROFILE Trials.
    Clin Lung Cancer. 2017 Mar 14. pii: S1525-7304(17)30081.
    PubMed     Text format     Abstract available


  350. SCHULKES KJ, Souwer ET, van Elden LJ, Codrington H, et al
    Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30049.
    PubMed     Text format     Abstract available


  351. TAKADA K, Toyokawa G, Okamoto T, Shimokawa M, et al
    A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30047.
    PubMed     Text format     Abstract available


  352. LI WN, Wang DF, Zhao YB, Qiu XS, et al
    Comparative Analysis for Diagnostic Yield of Small Cell Lung Cancer by Cytology and Histology During the Same Bronchoscopic Procedure.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30052.
    PubMed     Text format     Abstract available


  353. SPIGEL DR, Luft A, Depenbrock H, Ramlau R, et al
    An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30045.
    PubMed     Text format     Abstract available


  354. MORRISON EJ, Novotny PJ, Sloan JA, Yang P, et al
    Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer.
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30051.
    PubMed     Text format     Abstract available


  355. WU GX, Nelson RA, Kim JY, Raz DJ, et al
    Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30050.
    PubMed     Text format     Abstract available


  356. SONG Z, Wang X, Zheng Y, Su H, et al
    MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.
    Clin Lung Cancer. 2017;18:213-219.
    PubMed     Text format     Abstract available


  357. GUILBAULT C, Garant A, Faria S, Owen S, et al
    Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Mar 1. pii: S1525-7304(17)30046.
    PubMed     Text format     Abstract available


  358. MORIMOTO M, Okishio K, Akira M, Omachi N, et al
    Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017;18:e117-e127.
    PubMed     Text format     Abstract available


  359. ZHAO R, Kong W, Shang J, Zhe H, et al
    Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer.
    Clin Lung Cancer. 2017;18:127-131.
    PubMed     Text format     Abstract available


    February 2017
  360. ELLIS PM, Vella ET, Ung YC
    Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2017 Feb 16. pii: S1525-7304(17)30043.
    PubMed     Text format     Abstract available


  361. QIN A, Street L, Cease K, Viglianti BL, et al
    Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Feb 9. pii: S1525-7304(17)30041.
    PubMed     Text format     Abstract available


    January 2017
  362. SOO RA, Kubo A, Ando M, Kawaguchi T, et al
    Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
    Clin Lung Cancer. 2017 Jan 19. pii: S1525-7304(17)30020.
    PubMed     Text format     Abstract available


  363. SOCINSKI MA, Kaye FJ, Spigel DR, Kudrik FJ, et al
    Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease.
    Clin Lung Cancer. 2017;18:68-76.
    PubMed     Text format     Abstract available


  364. YONESHIMA Y, Morita S, Ando M, Miura S, et al
    Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017;18:100-103.
    PubMed     Text format     Abstract available


    October 2016
  365. ZHANG Y, Zhang Z, Huang X, Kang S, et al
    Therapeutic Efficacy Comparison of 5 Major EGFR-TKIs in Advanced EGFR-positive Non-Small-cell Lung Cancer: A Network Meta-analysis Based on Head-to-Head Trials.
    Clin Lung Cancer. 2016 Oct 27. pii: S1525-7304(16)30231.
    PubMed     Text format     Abstract available


    May 2016
  366. PLANCHARD D, Yokoi T, McCleod MJ, Fischer JR, et al
    A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study.
    Clin Lung Cancer. 2016;17:232-236.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: